E-LIB Suche - Ergebnisse für: Agostoni, G.

1

The cascade effect of autistic symptoms on pragmatics in sc..:

Sapienza, J. ; Agostoni, G. ; Cuoco, F....
Neuroscience Applied. 2 (2023) - p. 102504 , 2023

Link: https://doi.org/10.1016/..

2

Investigating the relationship between the kynurenine pathw..:

Spangaro, M. ; Sapienza, J. ; Agostoni, G....
Neuroscience Applied. 2 (2023) - p. 102496 , 2023

Link: https://doi.org/10.1016/..

3

Lifetime substance abuse and adverse childhood experiences ..:

Martini, F. ; Bosia, M. ; Marco, S....
Neuroscience Applied. 2 (2023) - p. 103559 , 2023

Link: https://doi.org/10.1016/..

4

Associated neurophysiological and neuropsychological patter..:

Agostoni, G. ; Zago, S. ; Bechi, M....
Neuroscience Applied. 2 (2023) - p. 103367 , 2023

Link: https://doi.org/10.1016/..

5

Exploring the interplay between kynurenine pathway, cogniti..:

Agostoni, G. ; Cuoco, F. ; Marchesi, A....
Neuroscience Applied. 1 (2022) - p. 100871 , 2022

Link: https://doi.org/10.1016/..

6

Cognitive impairment in schizophrenia – disentangling the r..:

Spangaro, M. ; Sapienza, J. ; Martini, F....
Neuroscience Applied. 1 (2022) - p. 100580 , 2022

Link: https://doi.org/10.1016/..

7

P.0488 Treatment-resistance as a predictor of cognitive rem..:

Spangaro, M. ; Martini, F. ; Bechi, M....
European Neuropsychopharmacology. 53 (2021) - p. S359-S360 , 2021

Link: https://doi.org/10.1016/..

8

P.205 White matter integrity, clinical symptoms and quality..:

Martini, F. ; Bollettini, I. ; Spangaro, M....
European Neuropsychopharmacology. 44 (2021) - p. S19-S20 , 2021

Link: https://doi.org/10.1016/..

9

P.0781 Words toward recovery: analyzing speech determinants..:

Cuoco, F. ; Frau, F. ; Bischetti, L....
European Neuropsychopharmacology. 53 (2021) - p. S570-S571 , 2021

Link: https://doi.org/10.1016/..

10

P.0782 Clozapine to N-Desmethylclozapine ratio in treatment..:

Martini, F. ; Spangaro, M. ; Bechi, M....
European Neuropsychopharmacology. 53 (2021) - p. S571 , 2021

Link: https://doi.org/10.1016/..

11

P.0466 Combined effect of treatment-resistance and autistic..:

Agostoni, G. ; Abu-Akel, A. ; Spangaro, M....
European Neuropsychopharmacology. 53 (2021) - p. S342-S343 , 2021

Link: https://doi.org/10.1016/..

12

P.0771 Targeting quality of life in schizophrenia: the fil ..:

Trezzani, S. ; Buonocore, M. ; Bosinelli, F....
European Neuropsychopharmacology. 53 (2021) - p. S562 , 2021

Link: https://doi.org/10.1016/..

13

PCN176 COST-EFFECTIVENESS OF SECOND-LINE NILOTINIB VERSUS D..:

Maheshwari, V. ; Tran, D. ; Agostoni, G...
Value in Health. 22 (2019) - p. S470 , 2019

Link: https://doi.org/10.1016/..

14

63. Modification of urinary steroid levels after administra..:

Agostoni, G. ; Kovarich, E. ; Garagiola, A...
Journal of Steroid Biochemistry. 6 (1975) 11-12 - p. xxx , 1975

Link: https://doi.org/10.1016/..

15

Prognostic impact of percutaneous coronary intervention in ..:

Cosentino, N ; Trombara, F ; Bonomi, A...
European Heart Journal. 44 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..